Login / Signup
Guillaume Wabont
(G Wabont)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Adverse Drug
Locally Advanced
Top Venues
Expert opinion on drug safety
European journal of clinical pharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
R Barus
,
C Potey
,
S Gautier
,
Guillaume Wabont
Ondansetron induced blindness: a pharmacovigilance database study.
Expert opinion on drug safety
(2023)
Guillaume Wabont
,
Sandrine Bergeron
,
Sophie Gautier
,
Romain Barus
Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase®.
European journal of clinical pharmacology
78 (8) (2022)